Like Chubb, the dividend yield of 2.1% that medical supply maker Becton Dickinson (BDX) presently offers just got hurdled by a risk-free payout. But at least Becton Dickinson has posted a couple of years’ worth of respectable sales growth.
Unfortunately, BDX is also like Chubb in the one place where it doesn’t want to be … the bottom line. Net income has fallen for two straight years despite the solid rises in the top line. It’s an alarming development for a company that has upped its dividend every year since 2003. But, with uncertainty stemming from Obamacare on the horizon, the first thing to suffer may well be the company’s now-comparably-weak payout.
As of this writing, James Brumley did not hold a position in any of the aforementioned securities.